关于子公司产品获得三类医疗器械注册证的公告 证券代码：600587 证券简称：新华医疗 公告编号：临 2026-012 山东新华医疗器械股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东新华医疗器械股份有限公司（以下简称"公司"或"新华医疗"）子公司 新华手术器械有限公司于近日收到国家药品监督管理局颁发的《中华人民共和国医 疗器械注册证》，具体情况如下： 一、医疗器械注册证的具体情况 1、产品名称：一次性使用腹腔内窥镜高频手术器械 2、注册证编号：国械注准 20263010413 3、注册人名称：新华手术器械有限公司 4、注册人住所：山东省淄博市高新区齐祥路 2779 号 5、生产地址：山东省淄博市高新区尊贤路 2999 号新华健康产业园 A2（委托 生产） 6、结构及组成：产品由单极抓钳、单极分离钳、单极剪刀、单极电极、双极 电凝钳组成。 7、型号、规格：单极抓钳 HDJZQ103、单极抓钳 HDJZQ105、单极抓钳 HDJZQ305、 单极抓钳 HDJZQ205、单极分离钳 HDJFL105、单极分 ...

内容概要：血液透析机作为血液透析治疗的核心设备，近年来市场需求量持续攀升，直接推动行业市场 规模快速扩容。2025年中国血液透析机行业市场规模达到41.31亿元，同比上涨6.4%。预计未来我国血 液透析机的市场规模将持续上升。一方面，随着我国人口老龄化进程加快，慢性肾脏病患者规模不断扩 大，使得需要接受血液透析治疗的患者人数持续增加。另一方面，受血液透析治疗费用较高影响，我国 血液透析治疗率相较于国外仍处于较低水平，未来具备较大的提升空间，也将进一步释放市场需求。此 外，国内企业也在不断加快自主研发和创新的步伐，努力提升产品的性能和质量水平，不仅能够更好地 适配国内市场的临床需求，也为行业整体的持续发展注入了强劲动力。 相关上市企业：威高血净（603014）、三鑫医疗（300453）、山外山（688410）、健帆生物 （300529）、宝莱特（300246）、新华医疗（600587）、天益医疗（301097）、维力医疗（603309） 等。 相关企业：重庆澳凯龙医疗科技股份有限公司、成都欧赛医疗器械有限公司、成都威力生生物科技有限 公司、四川威力生医疗科技有限公司、北京伟力新世纪科技发展股份有限公司、广州市暨 ...

(一)股东会召开的时间：2026年2月25日 (二)股东会召开的地点：淄博市高新技术产业开发区泰美路7号新华医疗科技园办公楼三楼会议室 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本次会议是否有否决议案：无 一、会议召开和出席情况 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集，董事长王玉全先生主持，会议采用现场投票与网络投票相结合的方式表 决，符合《公司法》、《公司章程》等法律、法规及规范性文件的规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事11人，列席11人； 2、公司总经理巩报贤先生、副总经理兼董事会秘书李财祥先生、副总经理屈靖先生、董事兼财务总监 周娟娟女士、副总经理朱庆国先生、副总经理王加强先生出席了会议。 二、议案审议情况 (一)累积投票议案表决情况 1、关于换选公司董事的议案 ■ (二)涉及重大事项，5%以下股东的表决情况 ■ (三)关于议案表决的有关 ...

证券日报网讯 2月25日，新华医疗在互动平台回答投资者提问时表示，公司严格按照监管规定履行信息 披露义务，公司经营情况已在定期报告中如实披露，股价波动受多重市场因素影响，公司将专注主业发 展，切实维护全体股东利益。 （编辑 丛可心） ...

证券日报网讯2月25日，新华医疗（600587）在互动平台回答投资者提问时表示，公司终止本次股权收 购事项未支付任何交易款项，亦不存在违约情形，本次终止未对公司财务状况及正常生产经营造成不利 影响。针对本次事项带来的市场关切，公司将持续严格遵守监管规定，审慎开展对外投资决策，不断提 升信息披露透明度，同时持续深耕医疗器械主业，以稳健的经营业绩夯实公司内在价值，加强与投资者 的沟通交流，切实维护全体股东的合法权益。 ...

证券代码：600587 证券简称：新华医疗 公告编号：临 2026-011 山东新华医疗器械股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 与网络投票相结合的方式表决，符合《公司法》、《公司章程》等法律、法规及规 范性文件的规定。 (五) 公司董事和董事会秘书的列席情况 1、公司在任董事11人，列席11人； 2、 公司总经理巩报贤先生、副总经理兼董事会秘书李财祥先生、副总经理屈靖 先生、董事兼财务总监周娟娟女士、副总经理朱庆国先生、副总经理王加强 先生出席了会议。 二、 议案审议情况 | 议案 | 议案 | 得票数 | 得票数占出席会议有效 | | 是否当选 | | --- | --- | --- | --- | --- | --- | | 序号 | 名称 | | 表决权的比例（%） | | | | 1.01 | 赵军 | 184,003,247 | | 99.0130 | 是 | (二) 涉及重大事项，5%以下股东的表决情况 一、 ...

北 京 市 东 城 区 北 三 环 东 路 36 号环球 贸易中心 B 座 11 层 电话（Tel）： 52213236/7 邮编（P.C）： 100013 北京市君致律师事务所 关于山东新华医疗器械股份有限公司 2026 年第一次临时股东会的法律意见书 致：山东新华医疗器械股份有限公司 北京市君致律师事务所（以下简称"本所"）受山东新华医疗器械股份有限公 司（以下简称"公司"）的委托，指派律师出席 2026 年 2 月 25 日上午 9:00 点召 开的公司 2026 年第一次临时股东会（以下简称"本次股东会"）；依据《中华人民 共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称 "《证券法》"）、《上市公司股东会规则》（以下简称"《股东会规则》"）等现行 法律、法规和其他规范性文件及《山东新华医疗器械股份有限公司章程》的规定， 特就公司本次股东会相关事宜，出具本法律意见书。 对本法律意见书的出具，本所特作如下声明： 一、本次股东会召集、召开的程序 公司董事会于 2026 年 1 月 30 日作出决议召集本次股东会，并于 2026 年 1 月 31 日在《中国证券报》、《上海证券报 ...

Core Viewpoint - On February 23, a total of 34 listed companies had their restricted shares unlocked, with a total market value of approximately 19.007 billion yuan [1] Group 1: Restricted Share Unlocking Details - Luzhou Laojiao (000568) had 2.0425 million shares unlocked under equity incentive restrictions - AVIC Xi'an Aircraft Industry (000768) had 4.3606 million shares unlocked under equity incentive restrictions - Hubei Energy (000883) had 19.2779 million shares unlocked under equity incentive restrictions - Jining Pharmaceutical (000919) had 1.92 million shares unlocked under equity incentive restrictions - Guangji Pharmaceutical (000952) had 2.5209 million shares unlocked under equity incentive restrictions - China Software (600536) had 57,200 shares unlocked under equity incentive restrictions - Xinhua Medical (600587) had 1.7845 million shares unlocked under equity incentive restrictions - Baoxin Software (600845) had 10.2578 million shares unlocked under equity incentive restrictions - China Railway (601390) had 55.9338 million shares unlocked under equity incentive restrictions - China Communications Construction (601800) had 5.593 million shares unlocked under equity incentive restrictions - StarNet Ruijie (002396) had 2.8342 million shares unlocked under equity incentive restrictions - Lopuskin (002333) had 22.3212 million shares unlocked under A-share issuance to legal persons - Wanbangda (300055) had 33.6538 million shares unlocked under A-share issuance to legal persons - Hangyang Co., Ltd. (002430) had 5.2049 million shares unlocked under equity incentive restrictions - Taijia Co., Ltd. (002843) had 949,600 shares unlocked under equity incentive restrictions - Nanda Optoelectronics (300346) had 130,000 shares unlocked under equity incentive restrictions - Anhui Natural Gas (603689) had 2.5064 million shares unlocked under equity incentive restrictions - Zhongyan Dadi (003001) had 97,200 shares unlocked under equity incentive restrictions - Yuanxiang New Materials (301300) had 30.2983 million shares unlocked with extended lock-up period - Yidao Information (001314) had 88.6187 million shares unlocked under pre-issuance restrictions - Tongda Electric (603390) had 579,500 shares unlocked under equity incentive restrictions - Yangzhou Jinqiao (603307) had 50 million shares unlocked under pre-issuance restrictions - Aili Home (603221) had 2.29 million shares unlocked under equity incentive restrictions - Zhili Fang (301312) had 333,900 shares unlocked under equity incentive restrictions - Kuntai Co., Ltd. (001260) had 83.25 million shares unlocked under pre-issuance restrictions - Entropy Technology (301330) had 92.5223 million shares unlocked with extended lock-up period - Yatong Precision (603190) had 596,100 shares unlocked under pre-issuance restrictions - Sanwang Communication (688618) had 87,400 shares unlocked - Longxun Co., Ltd. (688486) had 30.6312 million shares unlocked - Dize Pharmaceutical (688192) had 991,100 shares unlocked - Haohan Depth (688292) had 57.5177 million shares unlocked - Haizheng Biomaterials (688203) had 78.5601 million shares unlocked - Diaomicro (688381) had 55.9536 million shares unlocked - Zhongrun Optics (688307) had 29.8507 million shares unlocked [1]

Group 1 - The 1-year and 5-year LPR will be announced on February 24, with the current rates remaining unchanged at 3.0% and 3.5% respectively, marking the eighth consecutive month of stability [2] - The domestic refined oil price adjustment window will open on February 24, following a previous increase of 205 CNY/ton for gasoline and 195 CNY/ton for diesel on February 3 [3] Group 2 - The MSCI China Index will undergo adjustments effective February 27, 2026, including the addition of 37 stocks and the removal of 16 stocks [4] - Apple Inc. will hold its annual shareholder meeting on February 24, focusing on new product development, AI technology implementation, and supply chain adjustments [5] Group 3 - A total of 56.43 billion shares of restricted stocks will be released in the A-share market from February 24 to 27, with a market value exceeding 87 billion CNY [6] - Notable companies with significant restricted stock releases include Huaxi Nonferrous and *ST Songfa, each exceeding 10 billion CNY in market value [6] Group 4 - Two new stocks will be issued in the week following the holiday, with Hai Fei Man on February 24 and Gu De Electric Materials on February 25 [8]

Core Viewpoint - Zibo Vocational Technical University (ZVTU) is establishing a new ecosystem of vocational education through collaboration with enterprises, ensuring that students are "reserved" by companies before graduation and aligning educational programs with industry needs [1][2][7] Group 1: Talent Development - ZVTU has created a dynamic matching database for "majors-industry" to optimize its programs every five years, adding 12 emerging majors like artificial intelligence and big data while eliminating 11 outdated ones [2] - The university focuses on aligning its curriculum with the "Ten Strong Industries" of Shandong Province and the "Four Strong Industries" of Zibo City, ensuring that students learn relevant and cutting-edge content [2][3] - ZVTU has developed a "363+" professional cluster system that covers key regional industries such as high-end chemicals, new energy, and intelligent manufacturing, making "enrollment equals employment" a reality [2] Group 2: Industry Collaboration - ZVTU collaborates with 966 companies to offer 91 customized order classes and apprenticeship programs, where companies help design training plans and integrate job standards [3] - The university's order classes have led to high employment rates, with students from the Ideal Auto order class often fully booked by their third year and starting salaries typically above 6,000 yuan [3] Group 3: Practical Training - ZVTU has invested 300 million yuan to establish 42 enterprise-level training centers, providing students with hands-on experience using real industry equipment [4] - Students participate in real-world projects, such as battery management system development and e-commerce sales during major promotional events, generating significant sales revenue [4][5] Group 4: Research and Development - ZVTU has built a research system driven by industry needs, forming interdisciplinary teams to address technical challenges faced by companies, resulting in significant energy savings and efficiency improvements [6] - The university has tackled over 30 key technical challenges in the past three years, serving 145 companies and generating over 30 million yuan in funding [6] Group 5: Employment Outcomes - The integration of education and industry has led to high employment quality for graduates, with a job placement rate of 92% for automotive engineering and IoT majors, and an average starting salary of 6,500 yuan for pharmaceutical engineering graduates [6] - Over the past five years, ZVTU has trained more than 40,000 skilled technical talents, demonstrating the effectiveness of its educational model [6][7]